MedTrace Logo

Early Feasibility Study of Cartilage Defect Repair

NCT06823089 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-02-17

No results posted yet for this study

Summary

Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.

Conditions

  • Osteoarthritis, Hip
  • Femoroacetabular Impingement
  • Osteonecrosis
  • Legg-Calvé-Perthes Disease
  • Osteochondral Lesion
  • Hip Dysplasia

Interventions

DEVICE

ReNew Hip Implant

Surgical Intervention

Sponsors & Collaborators

  • MCRA

    collaborator INDUSTRY

  • Cytex Therapeutics, Inc.

    lead OTHER

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-06
Primary Completion
2031-10-31
Completion
2031-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823089 on ClinicalTrials.gov